Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis

ozdemir, ayse zehra; bıldırcın, fatma devran; Alper, Tayfun; AVCI, BAHATTIN; Kayabaş, Hatice; Karlı, Pervin

doi:10.5455/annalsmedres.2019.11.751

Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis

Hatice KAYABAŞ, (Samsun Kadın ve Çocuk Hastanesi, Samsun, Türkiye)

Fatma DEVRAN BILDIRCIN, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Samsun, Türkiye)

Bahattin AVCI, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Biyokimya Anabilim Dalı, Samsun, Türkiye)

Pervin KARLI, (Amasya Üniversitesi Araştırma Hastanesi, Kadın Hastalıkları ve Doğum Kliniği, Amasya, Türkiye)

Ayşe Zehra ÖZDEMİR, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Samsun, Türkiye)

Tayfun ALPER (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Samsun, Türkiye)

Annals of Medical Research

1 0

Yıl: 2019 Cilt: 26 Sayı: 12 Sayfa Aralığı: 2802 - 2806 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2019.11.751 İndeks Tarihi: 28-09-2020

Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis

Öz:

Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) andchorioamnionitis in risky cases.Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without waterbreaks. Levels of SAA were determined in maternal venous and umbilical cord blood.Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p<0,05). SAAvalues in the patients with clinical chorioamnionitis (n=9) were significantly higher (p<0,05) than both PPROM patients withoutchorioamnionitis (n=11) and the control group (n=20).Conclusion: In women at risk for PPROM in whom diagnosis cannot be established, blood SSA levels can be used as a marker. IncreasedSAA values in pregnant women with PPROM who were conservatively treated were considered a marker for chorioamnionitis.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Gabbe SG NJ, Simphson JL. Obstetrics;Normal and problem pregnancies. Third ed1996.
2. Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol 1996;20:369-74.
3. Scott JR DJ, KHammond CB, Spellacy WN. Danforth’s Obstetrics Gynecol. Seventy edition 1994.
4. Duff P. Premature rupture of the membranes in term patients. Semin Perinatol 1996;20:401-8.
5. Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989;160:890-906.
6. ACOG Committee on Practice Bulletins-Obstetrics a. Clinical management guidelines for obstetriciangynecologists. Obstetric Gynecology2007. p. 1007- 19.
7. Mercer BM, Goldenberg RL, Meis PJ, et al. The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;183:738- 45.
8. Joseph KS, Kramer MS, Marcoux S, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998;339:1434-9.
9. Bengtson JM, VanMarter LJ, Barss VA, et al. Pregnancy outcome after premature rupture of the membranes at or before 26 weeks’ gestation. Obstet Gynecol 1989;73:921-7.
10. Dale PO, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 1989;30:257-62.
11. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178-93.
12. Mercer BM. Management of preterm premature rupture of the membranes. Clin Obstet Gynecol 1998;41:870-82.
13. Mercer BM. Antibiotic treatment for preterm premature rupture of membranes. Am J Obstet Gynecol 1996;175:755-6.
14. Parry S, Strauss JF, 3rd. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-70.
15. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-7.
16. Asrat T, Garite TJ. Management of preterm premature rupture of membranes. Clin Obstet Gynecol 1991;34:730-41.
17. St Geme JW Jr, Murray DL, Carter J, et al. Perinatal bacterial infection after prolonged rupture of amniotic membranes: an analysis of risk and management. J Pediatr 1984;104:608-13.
18. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996;26:427-35.
19. Husby G, Natvig JB. A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest 1974;53:1054-61.
20. Laurenti F FF, Campi E, Ceri E, et al. Originale significato delle proteine “maqqiari” della fase acuta. Aggiornamenti in neonatalogia, 1996;4:173-93.
21. Petrunin DD, Griaznova IM, Petrunina Iu A, et al. Immunochemical identification of organ specific human placental alphal-globulin and its concentration in amniotic fluid. Akush Ginekol (Mosk) 1977:62-4.
22. Lee SE, Park JS, Norwitz ER, et al. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 2007;109:634-40.
23. Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993;36:795-808.
24. van de Laar R, van der Ham DP, Oei SG, et al. Accuracy of C-reactive protein determination in predicting chorioamnionitis and neonatal infection in pregnant women with premature rupture of membranes: a systematic review. Eur J Obstet Gynecol Reprod Biol 2009;147:124-9.
25. de Villiers WJ, Louw JP, Strachan AF, et al. C-reactive protein and serum amyloid A protein in pregnancy and labour. Br J Obstet Gynaecol 1990;97:725-30.
26. Cicarelli LM, Perroni AG, Zugaib M, et al. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin1beta, and interleukin-8 during and after delivery. Mediators Inflamm 2005;2005:96-100.
27. Laurenti F SP, Capolupo I, Fioravanti S, et al. Studio della siero-proteina amiloide A nell’etu neonatale. Rivista Italiana Disease Pediatria 1996;22/5-2:1201.
28. Benson MD, Cohen AS. Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum 1979;22:36-42.

APA	Kayabaş H, bıldırcın f, AVCI B, Karlı P, ozdemir a, Alper T (2019). Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. , 2802 - 2806. 10.5455/annalsmedres.2019.11.751
Chicago	Kayabaş Hatice,bıldırcın fatma devran,AVCI BAHATTIN,Karlı Pervin,ozdemir ayse zehra,Alper Tayfun Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. (2019): 2802 - 2806. 10.5455/annalsmedres.2019.11.751
MLA	Kayabaş Hatice,bıldırcın fatma devran,AVCI BAHATTIN,Karlı Pervin,ozdemir ayse zehra,Alper Tayfun Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. , 2019, ss.2802 - 2806. 10.5455/annalsmedres.2019.11.751
AMA	Kayabaş H,bıldırcın f,AVCI B,Karlı P,ozdemir a,Alper T Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. . 2019; 2802 - 2806. 10.5455/annalsmedres.2019.11.751
Vancouver	Kayabaş H,bıldırcın f,AVCI B,Karlı P,ozdemir a,Alper T Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. . 2019; 2802 - 2806. 10.5455/annalsmedres.2019.11.751
IEEE	Kayabaş H,bıldırcın f,AVCI B,Karlı P,ozdemir a,Alper T "Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis." , ss.2802 - 2806, 2019. 10.5455/annalsmedres.2019.11.751
ISNAD	Kayabaş, Hatice vd. "Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis". (2019), 2802-2806. https://doi.org/10.5455/annalsmedres.2019.11.751

APA	Kayabaş H, bıldırcın f, AVCI B, Karlı P, ozdemir a, Alper T (2019). Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. Annals of Medical Research, 26(12), 2802 - 2806. 10.5455/annalsmedres.2019.11.751
Chicago	Kayabaş Hatice,bıldırcın fatma devran,AVCI BAHATTIN,Karlı Pervin,ozdemir ayse zehra,Alper Tayfun Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. Annals of Medical Research 26, no.12 (2019): 2802 - 2806. 10.5455/annalsmedres.2019.11.751
MLA	Kayabaş Hatice,bıldırcın fatma devran,AVCI BAHATTIN,Karlı Pervin,ozdemir ayse zehra,Alper Tayfun Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. Annals of Medical Research, vol.26, no.12, 2019, ss.2802 - 2806. 10.5455/annalsmedres.2019.11.751
AMA	Kayabaş H,bıldırcın f,AVCI B,Karlı P,ozdemir a,Alper T Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. Annals of Medical Research. 2019; 26(12): 2802 - 2806. 10.5455/annalsmedres.2019.11.751
Vancouver	Kayabaş H,bıldırcın f,AVCI B,Karlı P,ozdemir a,Alper T Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis. Annals of Medical Research. 2019; 26(12): 2802 - 2806. 10.5455/annalsmedres.2019.11.751
IEEE	Kayabaş H,bıldırcın f,AVCI B,Karlı P,ozdemir a,Alper T "Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis." Annals of Medical Research, 26, ss.2802 - 2806, 2019. 10.5455/annalsmedres.2019.11.751
ISNAD	Kayabaş, Hatice vd. "Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis". Annals of Medical Research 26/12 (2019), 2802-2806. https://doi.org/10.5455/annalsmedres.2019.11.751